Anebulo Pharmaceuticals
observational study in patients | Anebulo Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
September 2022
Slide
43 of 53
Related slides by other companies
NeuroSense Therapeutics
Investor Presentation
January 2024
randomized prospective double blind placebo controlled study phase design placebo controlled road | NeuroSense Therapeutics
Pershing Square
Activist
September 2014
a recent case study key considerations | Pershing Square
Equillium
Investor Presentation
August 2023
phase first in human study of single ascending dose multiple ascending dose proof of concept study in celiac disease patients | Equillium
Equillium
Investor Presentation
November 2023
phase first in human study of single ascending dose multiple ascending dose proof of concept study in celiac disease patients | Equillium
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io